Shiiki et al. have examined levels of Prostate-specific Antigen (PSA) in saliva and its association with serum PSA in two groups of patients with prostate adenocarcinoma (PA), a low-serum PSA concentration group and a high-serum PSA concentration group with high risk of recurrence or metastasis. This evidence concerns the gene KLK3 and prostate adenocarcinoma.